Ernexa Therapeutics reports complete tumor elimination in ovarian cancer study
Go back to Ernexa Therapeutics reports complete tumor elimination in ovarian cancer study| (NASDAQ: ERNA) | Delayed: 4.02 -0.43 (9.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.45 | 52 Week High | $ | |||
| Open | $4.33 | 52 Week Low | $ | |||
| Day High | $4.46 | P/E | N/A | |||
| Day Low | $3.98 | EPS | $ | |||
| Volume | 60,272 | |||||

